Get startedLog in
    Picture of Medicinova logo

    MNOV — Medicinova News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    All News

    Brief: Medicinova Announces Extension Of Barda Contract To Develop MN-166 (Ibudilast) As A Medical Countermeasure Against Chlorine Gas-Induced Lung Injury

    Picture of Medicinova logoMedicinova
    30/06/2022 24:06
    June 29 (Reuters) - MediciNova Inc  MNOV.O :
    * MEDICINOVA ANNOUNCES EXTENSION OF BARDA CONTRACT TO
DEVELOP
MN-166 (IBUDILAST) AS A MEDICAL COUNTERMEASURE AGAINST CHLORINE
GAS-INDUCED LUNG INJURY
    * MEDICINOVA INC - CONTRACT WAS AMENDED TO EXTEND PERIOD OF
PERFORMANCE UNTIL MARCH 2023

Source text for Eikon:  ID:nGNXbbnt72 
Further company coverage:  MNOV.O 

 ((Reuters.Brief@thomsonreuters.com;))

    Recent news on Medicinova

    See all news